Anavex Life Sciences Corp (AVXL)

[nidan7500]

MayoMobile...clearly an "Above and Beyond effort" here. Just exceptional. MY GUESS is the MJF people must be delighted w/AVXL and A2-73 deliverables. They have here, the real truth about PDD. EXCELLENT STUFF.

- PDD is a tough indication, three failures recently across the industry. PDD has multiple pathologies which makes it so hard to treat. Our data is intriguing because we had a strong signal across the patients. All domains will be readout in the upcoming data release. Dose-dependent improvement in PDD, 30mg stopped decline, 50 mg improved patient. The 50mg patients "came out of the study with less dementia". 70% of this data has direct correlation with ADAS-COG (AD primary endpoint). REM was also improved and so was digital vigilance and episodic memory. No safety issues.